To ICN Pharmaceuticals, Inc.:

     We consent to the incorporation by reference in the registration statements
of ICN Pharmaceuticals,  Inc. on Form S-8 (File No. 33-56971) and Form S-3 (File
No.'s 333-08179,  333-10661,  333-13243,  333-13423 and 333-16409) of our report
dated March 4, 1997, on our audits of the consolidated  financial statements and
consolidated  financial  statement schedule of ICN  Pharmaceuticals,  Inc. as of
December 31, 1996 and 1995,  and for each of the three years in the period ended
December 31, 1996, which report, as it relates to 1996,  includes an emphasis of
a  matter  paragraph  related  to  the  Company's  net  monetary  assets  at ICN
Yugoslavia  which would be subject to foreign  exchange loss if a devaluation of
the  Yugoslavian  dinar were to occur,  included in this  Annual  Report on Form
10-K.



/s/ COOPERS & LYBRAND L.L.P.


Los Angeles, California
March 27, 1997